BIOTECH: HALOZYME GETS CREATIVE IN PURSUIT OF CASH
Biotech Financing
Originally published July 7, 2016 at 11:40 a.m., updated July 7, 2016 at 11:40 a.m.
Research scientist Li Zhu works in the lab at Halozyme Inc., which is developing drugs that target cancer. Photo by Melissa Jacobs.
San Diego — In today’s market, with valuations down and investors wary, it’s critical for biotechs to get creative when looking for cash to fuel research...
Take 1 minute to subscribe and you'll get this story immediately, plus:
Already a subscriber? Sign in
- 52 weekly issues
- Subscriber-only digital content every business day, plus full access to SDBJ.com archives
- Book of Lists — the most comprehensive business resource in San Diego
- San Diego 500 — influential business leaders you need to know